Tag: AAPL

Blue Horseshoe Stocks: MVIS, IBIO Recaps, Options Ideas & More

Monday’s Watchlist Movers

iBio, Inc. IBIO – A quick search of IBIO in our archives reveals a lengthy history of mentions. We have definitely seen some impressive moves from this play in the past. History tends to repeat itself, and did so once again as IBIO stood out on yesterday’s extended watchlist.

The stock made a solid intraday move, trading in a range from .72-.89. That was good for gains of up to 24%, and the move came on great-than-average volume. We’re going to keep a continued watch on this play; if it manages to break through its recent resistance area around 1.00-1.05, things could get very interesting from there.

Microvision, Inc. MVIS – This one appeared in yesterday’s gap-up watchlist, and it too would make a modest, yet solid move. The stock made a continual move-up in the first two hours of trading, rising from a low of 2.88 to a HOD of 3.44. That marked out an intraday gain of 19%

Morning Gapper Watchlist

These stocks are hitting our scanner today as they gap up in the premarket, and we’ve got options ideas corresponding to each:

Esperion Therapeutics, Inc. ESPR has released top-line results on one of its studies, noting that the trials have met their primary endpoint. In light of that, the stock is up big in early trading this morning. This is going to be a situation we’ll want to monitor as the session commences.

Options Ideas: ESPR 04/17 $90 Calls (Last traded at 3.50) for a longer-term swing trade idea. For shorter-term day trading opportunities, we can look to play in-the-money Weekly Calls, in the event that any dip and rip scenarios present themselves.

_________________________

American Airlines Group Inc. AAL announced today that it will now be listed on the S&P 500, and as a result, it’s trading up in the premarket. 

Options Idea:AAL 04/02 $55 Calls (Last traded at .23)

___________________________

Apple, Inc. AAPL is also opening up new avenues as it prepares to join the Dow Jones Industrial Average. It will replace AT&T(T) officially at the end of trading tomorrow. It too is gapping up in the premarket.

Options Idea: AAPL 04/02 $129 Calls (Last traded at 1.01)

Propanc Health Group Corp. PPCH

PPCH had already made a substantial move prior to our mentioning it in our daily report for the first time last Thursday. On that day we would witness a low of .0126, and in the few sessions since, the stock has begun to make yet another run.

Yesterday, PPCH topped out at a daily high of .027, which marks a 114% swing over our observed low.

Extended Watchlist:
IJJP, LLBO, BDE, GLUU, ARTX, NBY

Blue Horseshoe Stocks: Landmark Week for Options

Apple, Inc. AAPL – Options
–
We targeted AAPL Options for the first time in several months this week, and our timing in re-entering the mix was extremely fortuitous. Just to break it down for those who may have missed the bulk of this week’s coverage, we entered our ideas in Wednesday’s premarket report, citing AAPL Calls in the range of $113-117 as being high interest.

Things worked out great that first day, with three sets of call contracts in that range ($114, $115, $116) yielding up gains ranging from 167%-235%  AAPL continued to surge yesterday as it briefly breached the $119-mark, and as a result, those highs on our tracked calls were pushed significantly higher.

The $114 Calls, from Wednesday’s low of 2.23, managed to reach as high as 5.20, equal to an overnight increase of 133%

The $115 Calls saw their low at 1.58, and at the peak of yesterday’s session were trading for as much as 4.20. That marks a two-day jump of 166%

The $116 Calls overall move was also very impressive, ranging from 1.10-3.25, gains of up to 195% were made possible.

At the high end of our initial range of interest were the $117 Calls, which hit an early low of .45 yesterday, and subsequently touched a high of 2.35, registering as a single session move of 422% All in all, there was really no way to go wrong with our AAPL Calls this week following a big earnings beat by the tech giant.

Amazon.com, Inc. AMZN – Options

Speaking of exceeded expectations on earnings, AMZN smashed its previous two-quarter trend of losses by posting Q4 profits of $214M on just over $29B in sales. As a result, the stock spiked significantly, and continues to do so in this morning’s premarket. To take advantage of the resultant price action as we did with AAPL, we’ll be outlining some options ideas for AMZN as well.

For a possible intraday flip opportunities we’re looking at the Weekly $345 (Last traded: 1.49) and $350 Calls (Last traded: 1.24). For more of a longer-term interest, we’ll  keep an eye on the 02/20 $350 Calls (Last traded: 3.25).

Extended Watchlist:
DECN, OPBL, PEII

Blue Horseshoe Stocks: AAPL Options Recap

Apple, Inc. AAPL – Options Ideas

We decided to revisit AAPL Options yesterday morning just as the tech giant was coming off of a huge earnings beat that came post-market on Tuesday. If you recall, we highlighted Calls in the $113-117 area for potential intraday flip opportunities, and three sets of contracts in that range gave real standout performances with each making three significant swings over the course of the day. All of that price action added up to many fine chances for traders to reap sizable profits.

Here’s a look at specific figures of the kinds of gains that were possible, accompanied by a visual representation with the intraday charts:

$114 Calls: 2.54-4.26 (67%), 3.47-4.30(24%), 2.23-3.92(76%) Cumulative Total: 167%

$115 Calls: 1.90-3.40(79%), 2.67-3.40(27%), 1.58-3.06(94%) Cumulative Total: 200%

$116 Calls: 1.35-2.65(96%) , 2.00-2.65(33%) 1.10-2.27(106%) Cumulative Total: 235%

This scenario could not have been more textbook following a big earnings beat.  We’ve utilized this exact sort of trend on numerous occasions in the past, and as you can plainly see, it continues to be an effective strategy to this day.

We mentioned those contracts could be good for intraday and intraweek gains and we’re holding to that, so we’ll continue to have our eyes fixed on the AAPL Options Chain as the week draws to a close.

Extended Watchlist:
BESE, TAPM, ANFC, CLCN, GPRO, EA

Blue Horseshoe Stocks: Options Ideas, ADTM & More

Apple, Inc. AAPL – Options Ideas
It has been quite some time since we last looked in on the AAPL options chain, but we’re no strangers to the types of gains it affords. Just this past spring, we were able to track AAPL options to huge percentage gains.

Yesterday following market close AAPL earnings beat expectations by a mile, and as a result the stock is spiking significantly in premarket trading today. It may be possible to use this price action to our favor; we’d expect to see some early profit-taking lead to a familiar dip-and-rip scenario.

As the price rebounds we’ll be waiting with some potential options ideas. We’ll be monitoring Calls in the $113-117 range for potential intraday/intraweek flip opportunities.

Adaptive Medias, Inc. ADTM

We’ve had several recent opportunities with stocks rebounding off of their annual lows, and for that reason we’re going to tag ADTM this morning.

This stock’s 52-week low came on Monday, in the wake of the arrest of CEO Qayed Shareef on some very serious charges. The rebound off of those lows came yesterday as the company announced changes to its management structure following the immediate termination of Mr. Shareef. Acting COO Jim Waltz (Current CEO of Beanstock Media) has been unanimously supported by the board to assume the role of CEO.

We’ll look for ADTM to register higher lows and higher highs as it recovers off of its annual low. Prior to the disruption caused by the former CEO’s actions, the stock was trading in the 2.50-3.00 range; from current levels, a return to that area would mean gains in the neighborhood of 40-60%

 


Special Note:

We’ll also keep our eye on Vuzix Corp. VUZI. The stock appeared in our extended watchlist yesterday, and did make a modest increase during the session. This morning VUZI management will ceremoniously ring the opening bell to commemorate the company’s uplisting to the NASDAQ which begins today.

ROCHESTER, N.Y., Jan. 26, 2015 /PRNewswire via COMTEX/ — NASDAQ trading in “VUZI” to commence on January 28, 2015 Vuzix� Corporation (OTCQB: VUZI) (“Vuzix” or, the “Company”), a leading supplier of video eyewear and smart glasses products in the consumer, commercial and entertainment markets, announced today it has received approval from the NASDAQ Stock Market LLC (“NASDAQ”) for the listing of its common stock on the NASDAQ Capital Market. Vuzix common stock will retain the ticker symbol “VUZI” and will commence trading on the NASDAQ Capital Market on January 28, 2015.

Blue Horseshoe Stocks: PBR, ACHN, TMSH & More

Petroleo Brasiliero S.A. (Petrobras) PBR

We’ll kick things off this morning with PBR once again, as the stock had another banner day and behaved very much like we suggested it might. Yesterday we mentioned that the PBR chart was looking ripe for further northward movement and that’s just what we got.

The stock itself broke back over $15, which led to some prime opportunities in each and every set of options contracts that we outlined in our morning report. We said we’d be looking at Weekly Calls from $14-$15 for quick-flip intraday opportunities, and they all offered up some serious gains.

The $14 Calls traded from .74 to as high as 1.09, a chance for traders to score up to 47% in profits. The $14.50’s made a nice move up from .34 to .75, good for a nice double-bagger and more at +120% The $15’s fared extremely well also, running a whopping 290% from .11 up to .43.

Even our contracts of longer-term interest, the 07/19 $15 Calls (which we caught at a low of .25) made a solid intraday move from .54-.84, a highly respectable 55% increase.

All in all, for options traders, PBR was a paradise on Monday, and we’ll be continuously monitoring the situation as the week progresses. Major areas of resistance appear on the chart at 15.50 and 15.85, so failure to pierce through that channel would certainly be a signal to us to take profits off of the table. In order to keep our interest levels high, PBR will need to maintain support above the 15-dollar mark.

Achillion Pharmaceuticals, Inc. ACHN

Appearing in yesterday’s extended watchlist, ACHN was another play with potential to start off a new week. After a significant morning gap-up, the stock would touch a low of 3.72 before running as high as 4.82, an intraday move of 30%

This morning the company came with a well-timed release concerning its Hep-C drug, and the stock continues to blow its top. The high this morning in premarket trading is 6.47, making ACHN one that we’ll definitely be interested to follow. Per this morning’s PR, there’s a timeline for the testing of this drug leading all the way up to the end of the year, so we’ll stick ACHN on our longer-term radar as well.

NEW HAVEN, Jun 10, 2014 (GLOBE NEWSWIRE via COMTEX) — Initial cohort of HCV-infected patients begin dosing with ACH-3422 for seven days. Clinical trials may continue evaluating 200 mg of sovaprevir for HCV-infected patients. Timelines for reporting proof-of-concept results with ACH-3422, a proprietary uridine-analog nucleotide polymerase inhibitor, during the fall of 2014 and initiating all-oral combination studies by the end of 2014 remain on track >>> FULL PR

TransGlobal Assets, Inc. TMSH

We’ve been following TMSH since last week, and have not been disappointed. The stock has played out a textbook dip-and-rip scenario for the last three sessions straight, offering up many opportunities to make gains.

Yesterday, it came down as low as .0079 before ripping its way up to .0128, a healthy intraday increase of 62% Provided it continues to trade in this manner, we’ll be looking to take advantage of any similar swings to the ones we’ve seen already. We want to see it make higher lows, and break through the channel of resistance between the previous two sessions’ swing highs (.0128-.0139).

Side Note:

Even with so much else to talk about today, we can’t forget about another cash cow in Apple. AAPL Calls have been providing us with some excellent opportunities in recent weeks as well, and we’re still highly attuned to that situation as well.

Extended Watchlist:
DNAX, SPEX, AVNR, SGMS, ATEA, TPLM, KNDI

Get Our FREE Daily Reports!

SUBSCRIBE